In Q2 FY2026 (ended June 30, 2026), West Pharmaceutical Services reported revenue of $872.3M, up 13.8% year-over-year. Net income was $154.0M, up 16.8%, and diluted EPS was $2.15, up 18.1%. Operating income rose 16.5% to $179.1M. The company had $435.8M in cash, $2.99B in equity, and $202.9M in long-term debt.
•Revenue increased 13.8% YoY to $872.3M.
•Net income grew 16.8% YoY to $154.0M.
•Diluted EPS rose 18.1% YoY to $2.15.
•Operating income up 16.5% YoY to $179.1M.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.
West Pharmaceutical Services designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems. Its portfolio also includes syringe and cartridge components, including custom solutions for the needs of injectable drug applications
Administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies, and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges.
Its portfolio also includes self-injection devices, and a range of integrated solutions including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies.
The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and drug delivery systems consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies.
It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. Founded in 1923, West Pharmaceutical Services is headquartered in Exton, Pennsylvania.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products. The company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers, seals, syringe and cartridge components, and administration systems that enhance safe drug delivery. It also provides drug containment solutions such as vials, syringes, and cartridges, along with analytical lab services, regulatory expertise, and technical support. The Contract-Manufactured Products segment designs and assembles devices used in surgical, diagnostic, ophthalmic, injectable, and drug delivery systems, as well as consumer products. Its customers include biologic, generic, and pharmaceutical drug companies, as well as diagnostic and medical device firms.
Where is West Pharmaceutical Services (WST) listed and what currency does it trade in?
West Pharmaceutical Services, Inc. is listed on the New York Stock Exchange (NYSE) under the ticker symbol WST. The company trades in United States Dollars (USD), as it is headquartered in the United States. Being listed on a major US exchange provides liquidity and visibility to global investors. The NYSE is one of the world's largest stock exchanges, and WST's listing there reflects its status as a significant player in the healthcare sector. Investors can buy and sell shares of WST in USD, and the company's financial reports are also denominated in USD.
What sector and industry does West Pharmaceutical Services (WST) belong to?
West Pharmaceutical Services, Inc. operates in the Healthcare sector and is classified under the Medical Instruments & Supplies industry. This industry includes companies that manufacture medical devices, instruments, and supplies used in healthcare settings. As a Medical Instruments & Supplies company, West Pharmaceutical focuses on producing containment and delivery systems for injectable drugs, which are critical for the safe administration of medications. The Healthcare sector encompasses a broad range of services and products related to health, and West Pharmaceutical's role in providing packaging and delivery solutions for injectable drugs positions it as a key supplier to pharmaceutical and biotech companies.
In which geographic regions does West Pharmaceutical Services (WST) operate?
West Pharmaceutical Services, Inc. serves customers across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. The company's global footprint allows it to support pharmaceutical and healthcare clients worldwide. Its products, including stoppers, seals, syringe components, and drug containment solutions, are distributed internationally. The company's operations are structured to meet the needs of biologic, generic, and pharmaceutical drug companies in these regions. By having a presence in multiple continents, West Pharmaceutical can provide localized support and regulatory expertise, which is essential for the highly regulated pharmaceutical industry. The company's broad geographic reach also helps mitigate regional economic risks.
How does West Pharmaceutical Services (WST) generate revenue?
West Pharmaceutical Services generates revenue through two main segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment sells stoppers, seals, syringe and cartridge components, and administration systems for injectable drug packaging. It also offers drug containment solutions like vials and syringes, along with services such as analytical lab testing, regulatory support, and technical assistance. This segment primarily serves biologic, generic, and pharmaceutical companies. The Contract-Manufactured Products segment designs and assembles devices for surgical, diagnostic, ophthalmic, injectable, and drug delivery systems, as well as consumer products. Its customers include pharmaceutical, diagnostic, and medical device companies. By providing both proprietary components and contract manufacturing services, West Pharmaceutical captures value across the drug delivery supply chain.